NCI Awards Labcyte $196K to Develop Cancer Biomarker Validation System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Labcyte today announced it has been awarded $196,000 from the National Cancer Institute for the development of a system for early cancer detection.

The funding will go toward a collaborative cancer biomarker validation program that aims to develop a system that integrates "a suite of well-established biotechnologies," including Labcyte's proprietary acoustic liquid handling for arraying and MALDI mass spectrometry preparation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.